PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Effects of tamoxifen on urinary incontinence: Case report and review of literature.

Abstract Tamoxifen has been used in women with hormone receptor-positive breast cancer and has been shown to successfully reduce both recurrence and mortality. On the contrary, long-term use of tamoxifen has hormone-related urogenital side effects which decrease the quality of life of the patients.
PMID
Related Publications

The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities.

Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis.

Urogenital effects of selective estrogen receptor modulators: a systematic review.

Behavioural interventions for urinary incontinence in community-dwelling seniors: an evidence-based analysis.

Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.

Authors

Mayor MeshTerms
Keywords
Journal Title medicine
Publication Year Start




PMID- 28834864
OWN - NLM
STAT- In-Process
DA  - 20170823
LR  - 20170823
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 96
IP  - 34
DP  - 2017 Aug
TI  - Effects of tamoxifen on urinary incontinence: Case report and review of
      literature.
PG  - e6785
LID - 10.1097/MD.0000000000006785 [doi]
AB  - RATIONALE: Tamoxifen has been used in women with hormone receptor-positive breast
      cancer and has been shown to successfully reduce both recurrence and mortality.
      On the contrary, long-term use of tamoxifen has hormone-related urogenital side
      effects which decrease the quality of life of the patients. PATIENT CONCERNS: In 
      this case report, we present a breast cancer patient receiving tamoxifen who
      developed urinary incontinence; we discuss the effects of tamoxifen on urinary
      incontinence, which decreases quality of life of the patients who were evaluated 
      in our clinic. DIAGNOSES: Breast cancer, urinary incontinence. INTERVENTIONS:
      Temporarily discontinuing tamoxifen. OUTCOMES: Urinary incontinence resolved.
      LESSONS: Based on the case we reported and literature, estrogen can cause a
      dose-dependent increase in incontinence, but more preclinical and clinical
      studies of both estrogen and SERMs are needed to support this notion; given the
      fact that some small-scale clinical studies have not proven a direct relationship
      between tamoxifen and urinary incontinence. We suggest that clinicians faced with
      the issue should temporarily stop usage of the drug once the complaint of urinary
      incontinence arises.
FAU - Hasanov, Elshad
AU  - Hasanov E
AD  - aDepartment of Medical Oncology, Hacettepe University Cancer Institute
      bDepartment of Endocrinology and Metabolism, Hacettepe University School of
      Medicine, Ankara, Turkey cDepartment of Genitourinary Medical Oncology, the
      University of Texas MD Anderson Cancer Center, Houston, TX, USA.
FAU - Hasanov, Merve
AU  - Hasanov M
FAU - Kuria, Issa M
AU  - Kuria IM
FAU - Hasanov, Rovshan
AU  - Hasanov R
FAU - Rzazade, Reshad
AU  - Rzazade R
FAU - Jonasch, Eric
AU  - Jonasch E
FAU - Altundag, Kadri
AU  - Altundag K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
EDAT- 2017/08/24 06:00
MHDA- 2017/08/24 06:00
CRDT- 2017/08/24 06:00
AID - 10.1097/MD.0000000000006785 [doi]
AID - 00005792-201708250-00001 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2017 Aug;96(34):e6785. doi: 10.1097/MD.0000000000006785.